Zelda Therapeutics Ltd (ASX:ZLD)

Zelda Therapeutics Ltd (ASX:ZLD)

Share Price
$ 0.05
-0.001 (-2.04 %)
Market Cap
$36.26 m
Proactive Investors - Run By Investors For Investors

Zelda Therapeutics Ltd

Zelda Therapeutics Ltd (ASX:ZLD) is undertaking a human clinical trial focused on insomnia, autism and opioid reduction.

Market: ASX:ZLD
52-week High/Low: A$0.13 / A$0.03
Sector: Cannabis
Market Cap: $36.26 m
Website: www.zeldatherapeutics.com
col 3
col 4
col 5
col 6

Big Picture – A Deep Dive Examination of Zelda Therapeutics Ltd

Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use